pillbase.ru

Iclusig

Active substance: ponatinib

ponatinib

Centralised EU authorisationActive

Marketing holder: Incyte Biosciences Distribution B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • Iclusig
    TABLET, FILM COATED · PONATINIB HYDROCHLORIDE 45 mg/1
    63020-534
    Takeda Pharmaceuticals America, Inc.
  • Iclusig
    TABLET, FILM COATED · PONATINIB HYDROCHLORIDE 10 mg/1
    63020-536
    Takeda Pharmaceuticals America, Inc.
  • Iclusig
    TABLET, FILM COATED · PONATINIB HYDROCHLORIDE 30 mg/1
    63020-533
    Takeda Pharmaceuticals America, Inc.
  • Iclusig
    TABLET, FILM COATED · PONATINIB HYDROCHLORIDE 15 mg/1
    63020-535
    Takeda Pharmaceuticals America, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-8b7b-787e-b70f-97baa91a39c5,01a1208e-a07b-7755-9e10-05e69f87c6a9,01a12098-f92f-7c3b-84cf-1d8a326340a0,01a1209b-7e03-7104-9d4b-1104ff640d10;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002695
Registration status
Active
ATC code
L01EA05
Sources
  • product · EMA · EMEA/H/C/002695 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002695 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002695 · Verified 2026-10-09